Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Henry Khederian

Why NeuroMetrix Shares Are Skyrocketing

FDA Nasdaq Fibromyalgia

NeuroMetrix Inc (NASDAQ:NURO) shares are trading higher by 30.10% at $4.06 after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation device as an aid for reducing the symptoms of fibromyalgia.

Quell Fibromyalgia is a transcutaneous electrical nerve stimulation (TENS) device indicated as an aid for reducing the symptoms of fibromyalgia in adults with high pain sensitivity. The device is labeled for use only with compatible NeuroMetrix electrodes. NeuroMetrix received FDA Breakthrough Designation for the use of Quell to treat fibromyalgia in July 2021.

See Also: Why Cisco Systems Stock Is Falling Today

NeuroMetrix is a commercial-stage healthcare company.

According to data from Benzinga Pro, NeuroMetrix has a 52-week high of $38.75 and a 52-week low of $2.70.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Middle children are more cooperative than their siblings, study suggests
After decades of debate, one of the largest ever studies on birth order suggests it does actually make a difference
The Guardian - UK
The Guardian - UK
Work or play? The rise of online ‘kidfluencers’ is raising complex legal and ethical questions
Videos of children opening boxes of toys and playing with them have become a feature of online marketing – making stars out of children as young as two.
The Conversation
The Conversation
She's here for 'a kitchen pep talk' during the holiday whirlwind
If you’re feeling too overwhelmed to cook during the holidays, maybe a new book by Margaret Eby can help
The Independent UK
The Independent UK
All the celebrities that have supported Blake Lively after Justin Baldoni lawsuit
Lively has received a huge amount of support after filing the lawsuit against Baldoni
The Independent UK
The Independent UK
Where’s Santa? Here’s how to track his journey this Christmas Eve
NORAD’s Santa Tracker website launched this year on December 1
The Independent UK
The Independent UK
Gen Z’s politics are hard to categorize – and a harbinger of a new political order
The great clashes to come will be less between left and right than between those inside and outside a dying establishment
The Guardian - US
The Guardian - US
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.
Download on the AppStore Get it on Google Play